← Back to Search

Mobile Monitoring Device for Respiratory Disorders

N/A
Waitlist Available
Led By Sharon Chinthrajah, MD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
age 1 month or older with a diagnosis of chronic respiratory disease (ex. asthma, COPD), an acute respiratory illness or a healthy volunteer
Age 1 month or older with a diagnosis of chronic respiratory disease (ex. asthma, COPD), an acute respiratory illness or a healthy volunteer
Must not have
Significant cognitive impairment
Non-English speaking
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is looking at ways to help patients with respiratory disease monitor their symptoms and compliance with medication at home, as well as their vital signs, lung sounds, and lung function.

Who is the study for?
This trial is for individuals aged 1 month or older with chronic respiratory diseases like asthma or COPD, acute respiratory illnesses, or even healthy volunteers. Participants must be able to give consent themselves or through a parent if underage and speak English. Those with significant cognitive impairment cannot join.
What is being tested?
The study is testing the use of mobile monitoring devices that allow patients to track their respiratory health at home. This data will then be used by medical providers to potentially improve patient care and overall quality of life.
What are the potential side effects?
Since this trial involves non-invasive remote monitoring devices, there are no direct side effects from medications as in drug trials. However, participants may experience inconvenience or discomfort associated with using these devices regularly.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 1 month old and have a chronic respiratory condition, an acute respiratory illness, or am healthy.
Select...
I am over 1 month old and have a chronic respiratory condition, an acute respiratory illness, or am healthy.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have significant memory or thinking problems.
Select...
I do not speak English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Asthma Control Test (ACT)
PROMIS-10 survey

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Mobile MonitoringExperimental Treatment1 Intervention
Participants will be asked to use a smartphone or tablet application for remote monitoring or respiratory health. They will be followed over time with surveys as well as chart review to assess effects of adding these mobile monitoring elements to their standard care.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,468 Previous Clinical Trials
17,496,082 Total Patients Enrolled
Sharon Chinthrajah, MDPrincipal InvestigatorStanford University, Sean N. Parker Center for Allergy and Asthma Research
2 Previous Clinical Trials
484 Total Patients Enrolled

Media Library

Remote Monitoring of Respiratory Health Clinical Trial Eligibility Overview. Trial Name: NCT04739943 — N/A
Chronic Respiratory Disease Research Study Groups: Mobile Monitoring
Chronic Respiratory Disease Clinical Trial 2023: Remote Monitoring of Respiratory Health Highlights & Side Effects. Trial Name: NCT04739943 — N/A
Remote Monitoring of Respiratory Health 2023 Treatment Timeline for Medical Study. Trial Name: NCT04739943 — N/A
Chronic Respiratory Disease Patient Testimony for trial: Trial Name: NCT04739943 — N/A
~9 spots leftby Feb 2025